http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008522971-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2842 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate | 2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008522971-A |
| titleOfInvention | Delay or prevention of the development of multiple sclerosis |
| abstract | A method for treating a person at risk for recurrent MS is described. The present invention provides a method of treating a subject at risk of relapsed or progressive multiple sclerosis comprising the step of administering a VLA-4 binding antibody to the subject. In a preferred embodiment, the subject has experienced one clinical episode of localized neurological deficit. In a preferred embodiment, the antibody is administered within 4 weeks of the clinical episode. This neurological deficit can include one or more limb weakness, one or more limb paralysis, one or more limb tremors, uncontrollable muscle spasticity, loss or abnormal sensation, loss of coordination, balance Manifested by one or more symptoms selected from the group consisting of loss of sensation, loss of abstract thinking ability, loss of generalization ability, difficulty speaking, difficulty understanding speech, loss of monocular or binocular vision, and difficulty controlling the bladder or intestine Is done. |
| priorityDate | 2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.